日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacokinetics and Safety of Oliceridine Fumarate Injection in Chinese Patients with Chronic Non-Cancer Pain: A Phase I, Single-Ascending-Dose, Open-Label Clinical Trial

奥利西啶富马酸盐注射液在中国慢性非癌性疼痛患者中的药代动力学和安全性：一项 I 期单次递增剂量开放标签临床试验

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S461416
Ni, Yuncheng; Huang, Ranglang; Yang, Shuang; Yang, Xiao Yan; Zeng, Shan; Yao, An; Huang, Jie; Yang, Guoping
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma

EIF3B 通过抵消 SYVN1 介导的泛素化来稳定 PCNA，从而充当胆管癌的启动子

期刊:Aging-Us
影响因子:
doi:10.18632/aging.205759
Ranglang Huang, Wanpin Nie, Liangliang Mi, Chenjiao Yao, Haixia Zhu
肿瘤
胆管癌
发表日期：2024
文献求助 收藏

GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration

GSG2 敲低通过调节细胞增殖、凋亡和迁移来抑制胆管癌进展

期刊:Oncology Reports
影响因子:3.8
doi:10.3892/or.2021.8042
Jun Zhou, Wanpin Nie, Jiajia Yuan, Zeyu Zhang, Liangliang Mi, Changfa Wang, Ranglang Huang
信号转导
肿瘤
胆管癌
其它细胞
Apoptosis
发表日期：2021
文献求助 收藏

Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteers

给药后禁食时间对健康志愿者体内海曲波帕胺药代动力学和药效学的影响

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.14259
Yang, Guoping; Huang, Ranglang; Yang, Shuang; Zhang, Xingfei; Yang, Xiaoyan; Chen, Honghui; Huang, Zhijun; Guo, Chengxian; Pei, Qi; Tai, Yanfei; Shen, Yancong; Huang, Jie; Zou, Chan
发表日期：2020
文献求助 收藏